Therini Bio

MindImmune Therapeutics

This company develops monoclonal antibody therapeutics to treat neurodegenerative diseases and neuroinflammation for patients with central nervous system disorders.

Nilo Therapeuti

This biotechnology company develops medicines that target neural circuits to treat patients with autoimmune and inflammatory diseases.

Neuvasq

This company develops Wnt surrogate antibodies to restore blood-brain and blood-retina barriers for patients with vascular retinopathies and neurological disorders.

NeuroTherapia

This clinical-stage company develops oral small-molecule therapies targeting neuroinflammation for patients with Alzheimer's disease and other neurodegenerative disorders.

Basking Biosciences

The company develops reversible therapies targeting von Willebrand Factor for patients with acute thrombotic conditions, such as strokes.

NodThera

The company develops oral small molecule inhibitors for inflammatory diseases to treat patients with cardiovascular, neurological and metabolic conditions.

Rezera (formerly NodThera)

Rezera develops oral NLRP3 inhibitors to treat patients with cardiovascular and neurologic diseases, specifically focusing on peripheral artery disease and neuroinflammation.

MindImmune

This pharmaceutical company develops immunomodulatory monoclonal antibodies to treat patients suffering from neurodegenerative diseases like Alzheimer's by targeting brain inflammation.